title: Response to letter: Balancing risks and benefits of prucalopride for the treatment of chronic constipation in Asians.
authors.forename: M
authors.initials: M
authors.lastname: Ke
authors.forename: D
authors.initials: D
authors.lastname: Zou
authors.forename: Y
authors.initials: Y
authors.lastname: Yuan
authors.forename: Y
authors.initials: Y
authors.lastname: Li
authors.forename: L
authors.initials: L
authors.lastname: Lin
authors.forename: J
authors.initials: J
authors.lastname: Hao
authors.forename: X
authors.initials: X
authors.lastname: Hou
authors.forename: H J
authors.initials: HJ
authors.lastname: Kim
mesh_terms: D001572:Benzofurans / Q000627:therapeutic use*; D003248:Constipation / Q000188:drug therapy*; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male
chemical_list: D001572:Benzofurans; D005765:Gastrointestinal Agents